Pharmaceuticals & Biotechnology Editor | 09/14/2011
Dr. Ronald Frank, Head of Research Group, Chemical Systems Biology, Leibniz- Institut fur Molekulare Pharmakologie (FMP), speaks to Pharma IQ about the EU-OPENSCREEN project initiative, funding and plans. EU-OPENSCREEN, the European Infrastructure of Open Screening Platforms for Chemical Biology, integrates high-throughput screening platforms, chemical libraries, chemical resources for hit discovery and optimisation, bio- and cheminformatics support, and a database containing screening resu...
To continue reading this story Click Here
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More